Arlington Capital To Sell Micron Technologies To Catalent Pharma

(RTTNews) - Washington-based private equity firm Arlington Capital Partners, Tuesday said it will sell its healthcare portfolio company Micron Technologies, Inc. (MU) to Catalent Pharma Solutions, Inc. (CTLT). Financial terms of the deal were not disclosed.

Micron is a provider of particle size engineering technologies for bioavailability enhancement of pharmaceuticals. Commenting on the transaction, Joseph Drost, Micron Technologies' CEO, said: "During our partnership with Arlington, Micron posted record growth and profitability, brought new capabilities to market, and significantly invested in our people. Arlington's strategic counsel and capital support during this remarkable time has been a great asset. The future looks very bright and we are very pleased to be joining Catalent as we seek to continue to build upon our success."

Fairmount Partners represented Micron on the transaction, while Greenberg Traurig LLP provided legal counsel to the company.